Garbarz E, Farah B, Vuillemenot A, André F, Angioï M, Machecourt J, Bassand J P, Wolf J E, Danchin N, Prendergast B, Iung B, Vahanian A
Cardiology Department, Tenon Hospital, Paris, France.
Am J Cardiol. 1998 Sep 15;82(6):800-3, A9. doi: 10.1016/s0002-9149(98)00459-7.
We studied the in-hospital outcome of 138 consecutive patients who received abciximab as a "rescue" intervention for complicated coronary angioplasty in a high-risk clinical setting. "Rescue" treatment with abciximab was associated with clinical and angiographic success rates of 83% and 84%, respectively, whereas the risk of bleeding was higher in patients of low body weight.
